Cargando…

Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity

Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzystanek, Marek, Krzystanek, Ewa, Skałacka, Katarzyna, Pałasz, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730321/
https://www.ncbi.nlm.nih.gov/pubmed/33291692
http://dx.doi.org/10.3390/ijms21239265
_version_ 1783621656789385216
author Krzystanek, Marek
Krzystanek, Ewa
Skałacka, Katarzyna
Pałasz, Artur
author_facet Krzystanek, Marek
Krzystanek, Ewa
Skałacka, Katarzyna
Pałasz, Artur
author_sort Krzystanek, Marek
collection PubMed
description Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a key element of the PLD-dependent secondary messenger system. Changes in PLD activity are associated with the mechanism of action of olanzapine, an atypical antipsychotic. The aim of the present study was to assess the effect of short-term administration of the first-generation antipsychotic drugs haloperidol, chlorpromazine, and fluphenazine on membrane PLD activity in the rat brain. Animals were sacrificed for a time equal to the half-life of the antipsychotic drug in the brain, then the membranes in which PLD activity was determined were isolated from the tissue. The results indicate that only haloperidol in a higher dose increases the activity of phospholipase D. Such a mechanism of action of haloperidol has not been described previously. Induction of PLD activity by haloperidol may be related to its mechanism of cytotoxicity. The finding could justify the use of PLD inhibitors as protective drugs against the cytotoxicity of first-generation antipsychotic drugs like haloperidol.
format Online
Article
Text
id pubmed-7730321
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77303212020-12-12 Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity Krzystanek, Marek Krzystanek, Ewa Skałacka, Katarzyna Pałasz, Artur Int J Mol Sci Communication Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a key element of the PLD-dependent secondary messenger system. Changes in PLD activity are associated with the mechanism of action of olanzapine, an atypical antipsychotic. The aim of the present study was to assess the effect of short-term administration of the first-generation antipsychotic drugs haloperidol, chlorpromazine, and fluphenazine on membrane PLD activity in the rat brain. Animals were sacrificed for a time equal to the half-life of the antipsychotic drug in the brain, then the membranes in which PLD activity was determined were isolated from the tissue. The results indicate that only haloperidol in a higher dose increases the activity of phospholipase D. Such a mechanism of action of haloperidol has not been described previously. Induction of PLD activity by haloperidol may be related to its mechanism of cytotoxicity. The finding could justify the use of PLD inhibitors as protective drugs against the cytotoxicity of first-generation antipsychotic drugs like haloperidol. MDPI 2020-12-04 /pmc/articles/PMC7730321/ /pubmed/33291692 http://dx.doi.org/10.3390/ijms21239265 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Krzystanek, Marek
Krzystanek, Ewa
Skałacka, Katarzyna
Pałasz, Artur
Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title_full Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title_fullStr Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title_full_unstemmed Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title_short Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
title_sort enhancement in phospholipase d activity as a new proposed molecular mechanism of haloperidol-induced neurotoxicity
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730321/
https://www.ncbi.nlm.nih.gov/pubmed/33291692
http://dx.doi.org/10.3390/ijms21239265
work_keys_str_mv AT krzystanekmarek enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity
AT krzystanekewa enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity
AT skałackakatarzyna enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity
AT pałaszartur enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity